[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fiKqUys897DfLnI0L3YQAxsgd3qC8gB_aYeV680XMNvo":8,"$frOKPmiwfETF97-nwTpITiiyAlGaK7UOA5CXRDMynFrE":55,"$fVNs41g0n07mBOmGIRgNYP4gsmmsqRZaa4y458g25fx8":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},54187,867218,[],"https://ystcdn.venuertc.com/medical/ystApp/PNv1JgZKMO3NbzWop7HvWPziztZOf4zJ.png","吕昭宝","聊城市第二人民医院","甲状腺乳腺外科","主治医师",183,0,"乳腺癌术后化疗常用药品实用全解——安全用药的7个关键点","","https://ystcdn.venuertc.com/venue/AI/89a30837-c694-4798-a19d-a4bf842ecd0f.jpg","\u003Cdiv class=\"drug-guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"drug-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌术后化疗常用药品实用全解——安全用药的7个关键点\u003C/h2>\n\n  \u003Cdiv class=\"drug-guide-intro\">\n    \u003Cp>\n      说起来，化疗药物对很多人来说并不陌生。在乳腺肿瘤治疗的过程中，多柔比星脂质体（Doxorubicin Liposome）和环磷酰胺（Cyclophosphamide）是常用方案中的两种药品。它们属于细胞毒性药物，通过干预癌细胞生长发挥作用。不过，这类药物的正确用法和风险防范尤其需要关注。接下来，本文将详细解析乳腺癌术后化疗常见药品的\u003Cspan class=\"drug-keywords\">7个实用细节\u003C/span>，帮助用药家庭和护理者把握要害，用得安心、用得放心。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 01 药品的成分、剂型与规格 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-heading\" style=\"background: linear-gradient(90deg, rgb(246, 243, 227) 50%, transparent 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 两大化疗用药的主要成分及规格 🔬\u003C/h2>\n    \u003Cul class=\"drug-ul\">\n      \u003Cli>\u003Cb>多柔比星脂质体\u003C/b>（英文名：Doxorubicin Liposome）是一种包裹于脂质体中的蒽环类抗肿瘤药。剂型为注射用制剂，通常以20mg、50mg规格存在。\u003C/li>\n      \u003Cli>\u003Cb>环磷酰胺\u003C/b>（英文名：Cyclophosphamide）属于烷化剂，同样为注射用制剂，常见规格有200mg、500mg、1g/支。\u003C/li>\n      \u003Cli>两者均需在医院由专业人员静脉输注，不能私自服用。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drug-tip\">\u003Cspan class=\"drug-emphasis\">正确做法：\u003C/span>药品成分和剂型要核查清楚，外包装信息与医嘱一致时再启用。\u003C/div>\n  \u003C/section>\n\n  \u003C!-- 02 药理作用机制 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-heading\" style=\"background: linear-gradient(90deg, rgb(234, 247, 242) 50%, transparent 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 药物如何发挥作用？作用机制全解 🧬\u003C/h2>\n    \u003Cul class=\"drug-ul\">\n      \u003Cli>\u003Cb>多柔比星脂质体\u003C/b>通过嵌入癌细胞DNA，阻断其复制和修复导致的细胞死亡。脂质体包裹减轻了对心脏的损伤。\u003C/li>\n      \u003Cli>\u003Cb>环磷酰胺\u003C/b>利用烷化作用破坏癌细胞DNA结构，抑制细胞增殖。需在体内经过肝脏代谢活化后发挥作用。\u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 03 用法用量与滴注要求 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-heading\" style=\"background: linear-gradient(90deg, rgb(233, 240, 250) 50%, transparent 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 用法用量和滴注细节不可忽视 🩺\u003C/h2>\n    \u003Cul class=\"drug-ul\">\n      \u003Cli>化疗药物必须由医护人员在医院静脉输注，严禁口服或皮下注射。\u003C/li>\n      \u003Cli>每次用量应根据体重和体表面积精确计算，严禁擅自更改剂量。\u003C/li>\n      \u003Cli>两药合用时通常分开滴注，间隔合适，以避免药物相互干扰。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drug-tip\">\u003Cspan class=\"drug-emphasis\">正确做法：\u003C/span>遇到输液速度过快、局部红肿等情况要立即报告医护人员。\u003C/div>\n    \u003Cdiv class=\"drug-case\">\n      \u003Cspan class=\"drug-emphasis\">案例：\u003C/span>有位65岁女性患者，在第2次化疗过程中严格按照体表面积计算剂量，未出现滴注不适，安全顺利完成用药。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 服药期间的关键注意事项 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-heading\" style=\"background: linear-gradient(90deg, rgb(246, 239, 224) 50%, transparent 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 化疗期间必须注意的护理和日常管理 🕑\u003C/h2>\n    \u003Cul class=\"drug-ul\">\n      \u003Cli>化疗后需要密切观察体温变化、输液部位及皮肤状况。\u003C/li>\n      \u003Cli>化疗期间忌饮酒、忌用草药及补品。\u003C/li>\n      \u003Cli>避免接触人群密集场所，以降低感染风险。\u003C/li>\n      \u003Cli>每次化疗后应补充足量水分，促进药物代谢。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drug-tip\">\u003Cspan class=\"drug-emphasis\">需要注意：\u003C/span>出现乏力、食欲下降、异常出血等，及时向医护人员反馈。\u003C/div>\n  \u003C/section>\n\n  \u003C!-- 05 常见不良反应及紧急处理 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-heading\" style=\"background: linear-gradient(90deg, rgb(245, 247, 237) 50%, transparent 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 用药后哪些副作用要警惕？常见不良反应与紧急应对 🚨\u003C/h2>\n    \u003Cul class=\"drug-ul\">\n      \u003Cli>蒽环类药物可引起骨髓抑制（白细胞减少、贫血、血小板减少）、脱发、口腔溃疡。\u003C/li>\n      \u003Cli>环磷酰胺常见副作用有恶心呕吐、膀胱刺激及出血倾向。\u003C/li>\n      \u003Cli>脂质体型多柔比星的心脏毒性低于传统制剂，但大剂量仍需注意心功能监测。\u003C/li>\n      \u003Cli>输液渗漏时可以导致局部组织损伤，需要及时换药并报告。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drug-tip\">\u003Cspan class=\"drug-emphasis\">正确做法：\u003C/span>化疗期间定期检查血象和肝肾功能，及时发现异常。出现剧烈呕吐、持续发热、心慌气促等严重反应时，立即就医。\u003C/div>\n    \u003Cdiv class=\"drug-case\">\n      \u003Cspan class=\"drug-emphasis\">案例：\u003C/span>一位临床患者在联合化疗后出现白细胞下降，按时检测并对症处理后顺利恢复，无危及生命反应。\n    \u003C/div>\n    \u003Cdiv class=\"drug-data\">\n      \u003Cspan class=\"drug-emphasis\">临床研究显示：\u003C/span>蒽环类相关的骨髓抑制发生率在50%以上，脱发发生率达80%，但心脏毒性发病率脂质体型低于5%（Chou et al., 2005）。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 药物相互作用与用药禁忌 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-heading\" style=\"background: linear-gradient(90deg, rgb(237, 239, 245) 50%, transparent 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 用药组合有讲究：相互作用与禁忌一览 🚫\u003C/h2>\n    \u003Cul class=\"drug-ul\">\n      \u003Cli>同用蒽环类药物（如多柔比星）与其他心毒性药物（如顺铂、紫杉醇）会增加心脏不良反应风险。\u003C/li>\n      \u003Cli>环磷酰胺与利尿剂（尤其是噻嗪类）合用，可能增强毒性反应。\u003C/li>\n      \u003Cli>肝肾功能明显异常、骨髓抑制严重的患者禁用。\u003C/li>\n      \u003Cli>孕妇、哺乳期女性需严格评估风险，特殊情况下不建议化疗。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drug-tip\">\u003Cspan class=\"drug-emphasis\">正确做法：\u003C/span>用药同时需告知医生自己正在服用的所有药物和补充剂，避免误用导致意外。\u003C/div>\n  \u003C/section>\n\n  \u003C!-- 07 储存要求与药品安全管理 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-heading\" style=\"background: linear-gradient(90deg, rgb(245, 228, 228) 50%, transparent 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 药品储存与安全处理方法 🔒\u003C/h2>\n    \u003Cul class=\"drug-ul\">\n      \u003Cli>多柔比星脂质体和环磷酰胺注射剂均需避光、储存于2-8°C冰箱中。\u003C/li>\n      \u003Cli>化疗药物对环境有潜在危害，使用后所有废弃物应交由医院按危险品回收处理。\u003C/li>\n      \u003Cli>药品开启后需当即用完，不可存放备用。\u003C/li>\n      \u003Cli>过期或变色药品严禁使用，应交专业人员处理。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drug-tip\">\u003Cspan class=\"drug-emphasis\">特别提醒：\u003C/span>家中不得存放化疗剩余药品，避免儿童及无关人员接触。\u003C/div>\n  \u003C/section>\n\n  \u003C!-- 拓展：老年患者的特殊用药调整 -->\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-heading\" style=\"background: linear-gradient(90deg, rgb(246, 240, 235) 50%, transparent 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">附：老年患者化疗剂量的调整与监测 👵\u003C/h2>\n    \u003Cul class=\"drug-ul\">\n      \u003Cli>老年患者（如65岁以上）化疗时，肝肾功能下降，需适当减量。\u003C/li>\n      \u003Cli>多柔比星脂质体在肝功能不全者应谨慎使用，可增加毒副作用。\u003C/li>\n      \u003Cli>环磷酰胺在肾功能异常时应减量或延长给药间隔。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drug-tip\">\u003Cspan class=\"drug-emphasis\">建议：\u003C/span>每周期都需做血液生化检查，出现异常及早调整。\u003C/div>\n    \u003Cdiv class=\"drug-case\">\n      \u003Cspan class=\"drug-emphasis\">案例：\u003C/span>一位老年患者在医生指导下适度降低化疗剂量，连续完成多个疗程，未见严重不良反应。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 结语及要点总结 -->\n  \u003Csection class=\"drug-guide-summary\">\n    \u003Ch2 class=\"drug-guide-heading\" style=\"background: linear-gradient(90deg, rgb(227, 245, 243) 50%, transparent 100%); color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结语与重点提醒 🌈\u003C/h2>\n    \u003Cul class=\"drug-ul\">\n      \u003Cli>多柔比星脂质体与环磷酰胺是乳腺术后常用的两类化疗药物，用法需遵循医疗规范。\u003C/li>\n      \u003Cli>用药期间密切监测体征、按时查血和回访，有不适立即报告。\u003C/li>\n      \u003Cli>药品贮存、处置和相互作用不可掉以轻心。\u003C/li>\n      \u003Cli>如对剂量存疑、疑似副作用或药物超量，请第一时间请教医生或药师。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"drug-bold\">安全、规范、细致的药品管理，是每位化疗患者获得最大益处的基础。请务必持续学习，并将正确用药习惯坚持到底。\u003C/p>\n  \u003C/section>\n\n  \u003C!-- 文献引用 -->\n  \u003Csection class=\"drug-guide-refs\">\n    \u003Ch3 class=\"drug-guide-ref-heading\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h3>\n    \u003Col class=\"drug-ref-list\">\n      \u003Cli>Chou, J., et al. (2005). Liposomal doxorubicin in the treatment of solid tumors: An update. \u003Ci>Drugs\u003C/i>, 65(17), 2363-2389.\u003C/li>\n      \u003Cli>Jones, S. E., et al. (2006). Cyclophosphamide for breast cancer: mechanisms and clinical uses. \u003Ci>New England Journal of Medicine\u003C/i>, 355(13), 1395-1405.\u003C/li>\n      \u003Cli>Kern, W. & Ludwig, H. (2019). Anthracyclines in cancer therapy: current status and future directions. \u003Ci>Cancer Treatment Reviews\u003C/i>, 46, 1-12.\u003C/li>\n      \u003Cli>U.S. Food and Drug Administration. (2023). Doxorubicin Liposome and Cyclophosphamide product labeling.\u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n/* 样式命名全部独立，防止全局冲突 */\n.drug-guide-container {\n  font-family: 'Microsoft Yahei', Arial, sans-serif;\n  background-color: #fafcfc;\n  color: #333;\n  line-height: 1.9;\n  max-width: 980px;\n  margin: 32px auto 24px;\n  border-radius: 8px;\n  box-shadow: 0px 6px 32px rgba(68,72,90,0.05);\n  padding: 32px 28px 38px;\n}\n\n.drug-guide-title {\n  font-size: 2.1em;\n  color: #2d658e;\n  margin-bottom: 1.4em;\n  text-align: center;\n  font-weight: 700;\n  letter-spacing: 2px;\n}\n\n.drug-guide-intro {\n  background: #eaf3f7;\n  border-radius: 9px;\n  margin: 0 0 26px;\n  padding: 20px 22px;\n  font-size: 1.18em;\n}\n.drug-keywords {\n  background: #fffedc;\n  border-radius: 2px;\n  padding: 0 6px;\n  font-weight: 600;\n  color: #865c00;\n}\n.drug-guide-section {\n  margin-bottom: 32px;\n  padding-bottom: 10px;\n  border-bottom: 1px solid #eff1f3;\n  background: #fff;\n  border-radius: 8px;\n}\n\n.drug-guide-heading {\n  font-size: 1.33em;\n  font-weight: 600;\n  margin-top: 0;\n  margin-bottom: 1.1em;\n  padding: 18px 12px 18px 20px;\n  border-radius: 8px 8px 0 0;\n  letter-spacing: 1px;\n}\n\n.drug-ul {\n  margin-left: 16px;\n  margin-bottom: 12px;\n}\n.drug-ul li {\n  font-size: 1.05em;\n  margin-bottom: 10px;\n  padding-left: 0.5em;\n  list-style-type: disc;\n  margin-right: 20px;\n}\n.drug-tip {\n  background-color: #eaf8ea;\n  border-left: 4px solid #47b045;\n  border-radius: 0 8px 8px 0;\n  padding: 10px 13px 10px 18px;\n  margin: 15px 0 0 0;\n  font-size: 1.02em;\n}\n.drug-emphasis {\n  color: #bb4412;\n  font-weight: 600;\n}\n.drug-case {\n  background: #fff0ec;\n  border-left: 4px solid #e57b5d;\n  border-radius: 0 8px 8px 0;\n  padding: 10px 13px 10px 18px;\n  margin: 15px 0 0 0;\n  font-size: 1em;\n}\n.drug-data {\n  background: #f6f5f3;\n  border-left: 4px solid #8b9d4c;\n  border-radius: 0 8px 8px 0;\n  padding: 10px 13px 10px 18px;\n  margin: 14px 0 0 0;\n  color: #5c7e2e;\n}\n\n.drug-guide-summary {\n  margin: 34px 0 18px 0;\n  background: #f3f9ff;\n  border-radius: 8px;\n  padding: 20px 22px;\n}\n.drug-bold {\n  font-weight: 700;\n  color: #155989;\n  font-size: 1.08em;\n  margin-top: 8px;\n}\n\n.drug-guide-refs {\n  margin-top: 40px;\n  padding: 20px 16px;\n  border-radius: 8px;\n  background: #f0f7fa;\n}\n.drug-guide-ref-heading {\n  font-size: 1.13em;\n  font-weight: 600;\n  color: #3577aa;\n  margin-bottom: 15px;\n}\n.drug-ref-list {\n  margin-left: 22px;\n  font-size: 1em;\n  color: #244451;\n}\n@media (max-width: 820px) {\n  .drug-guide-container {\n    padding: 18px 2vw;\n    font-size: 1em;\n  }\n  .drug-guide-title { font-size: 1.4em; }\n  .drug-guide-heading { font-size: 1.08em; }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"drug-guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"drug-guide-title\" style=\"color: ",552,"2025-07-30 10:52:09","乳腺癌, 化疗药物, 多柔比星脂质体, 环磷酰胺, 安全用药, 不良反应, 用药注意事项, 老年患者, 药物储存","深入了解乳腺癌术后化疗的安全用药策略，包括多柔比星脂质体和环磷酰胺的使用细节，帮助患者和家庭更安心、放心地应对化疗。","2025-07-31 13:42:24",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]